Adiponectin upregulates SHBG production: Molecular mechanisms and potential implications

Endocrinology

Volumn 155, Issue 8, 2014, Pages 2820-2830

  Simó, Rafael ^a,b,c   Saez Lopez, Cristina ^a,b,c   Lecube, Albert ^d   Hernandez, Cristina ^a,b,c   Fort, Jose Manuel ^e   Selva, David M ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

^d HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; FATTY ACIDS; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIPID METABOLISM; LIVER; MALE; OBESITY; OXIDATION-REDUCTION; SEX HORMONE-BINDING GLOBULIN; UP-REGULATION;

EID: 84905020685     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1072     Document Type: Article

References (45)

1. Siiteri PK, Murai JT, Hammond GL, Nisker J.A., Raymoure WJ, Kuhn RW. The serum transport of steroid hormones. Recent Prog Horm Res. 1982; 38:457-510.
2. Li C, Ford ES, Li B, Giles WH, Liu S. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care. 2010; 33:1618-1624.
3. Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009; 361:1152-1163.
4. Bonnet F, Balkau B, Malécot JM, et al. DESIR Study Group. Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels. Eur J Endocrinol. 2009; 161:81-85.
5. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al. SWAN Investigators. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation. 2005; 111:1242-1249.
6. Karim R, Hodis HN, Stanczyk FZ, Lobo R.A., Mack WJ. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab. 2008; 93:131-138.
7. de Moor P, Joossens JV. An inverse relation between body weight and the activity of the steroid binding-globulin in human plasma. Steroidologia. 1970; 1:129-136.
8. Kopelman PG, Pilkington TR, White N, Jeffcoate SL. Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf). 1980; 12:363-369.
9. Pascal N, Amouzou EK, Sanni A, Namour F, Abdelmouttaleb I., Vidailhet M, Guéant JL. Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus. Am J Clin Nutr. 2002; 76:239-244.
10. Barbe P, Bennet A, Stebenet M, Perret B., Louvet JP. Sex-hormone-binding globulin and protein-energy malnutrition indexes as indicators of nutritional status in women with anorexia nervosa. Am J Clin Nutr. 1993; 57:319-322.
11. Simó R, Barbosa-Desongles A, Lecube A, Hernandez C, Selva DM. Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulin. Diabetes. 2012; 61:372-382.
12. Simó R, Barbosa-Desongles A, Sáez-Lopez C, Lecube A, Hernandez C, Selva DM. Molecular mechanism of TNFα-induced down-regulation of SHBG expression. Mol Endocrinol. 2012; 26:438-446.
13. Simó R, Barbosa-Desongles A, Hernandez C, Selva DM. IL1β down-regulation of sex hormone-binding globulin production by decreasing HNF-4α via MEK-1/2 and JNK MAPK pathways. Mol Endocrinol. 2012; 26:1917-1927.
14. Sladek FM, Zhong WM, Lai E, Darnell JE Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990; 4:2353-2365.
15. Hertz R, Magenheim J, Berman I, Bar-Tana J. Fatty acyl-CoA thio-esters are ligands of hepatic nuclear factor-4alpha. Nature. 1998; 392:512-516.
16. Yuan X, Ta TC, Lin M, et al. Identification ofanendogenous ligand bound to a native orphan nuclear receptor. PLoS One. 2009; 4: e5609.
17. Jänne M, Hammond GL. Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J Biol Chem. 1998; 273:34105-34114.
18. Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccha-ride-induced lipogenesis regulates the human hepatic sex hormonebinding globulin gene. J Clin Invest. 2007; 117:3979-3987.
19. Selva DM, Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepa-tocyte nuclear factor-4alpha. J Mol Endocrinol. 2009; 43:19-27.
20. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257:79-83.
21. Oh KW, Lee WY, Rhee EJ, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf). 2005; 63:131-138.
22. Maeda K, Okubo K, Shimomura I, Funahashi T., Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adi-Pose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996; 221:286-289.
23. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26:439-451.
24. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003; 423:762-769.
25. Viollet B, Guigas B, Leclerc J, et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf). 2009; 196:81-98.
26. Hardie DG, Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays. 2001; 23:1112-1119.
27. Carling D, Clarke PR, Zammit VA, Hardie DG. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglu-taryl-CoA reductase kinase activities. Eur J Biochem. 1989; 186: 129-136.
28. Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature. 2005; 437: 1109-1111.
29. Yasui T, Tomita J, Miyatani Y, et al. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations. Clin Chim Acta. 2007; 386:69-75.
30. Gannagé-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol. 2006; 155:167-176.
31. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31 Suppl 1:S55-S60.
32. Saha AK, Persons K, Safer JD, Luo Z, Holick M.F., Ruderman NB. AMPK regulation of the growth of cultured human keratinocytes. Biochem Biophys Res Commun. 2006; 349:519-524.
33. Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipo-kine in obesity related liver diseases. World J Gastroenterol. 2011; 17:2801-2811.
34. Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003; 148:293-300.
35. Kotronen A, Yki-Järvinen H, Aminoff A, et al. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur J Endocrinol. 2009; 160:593-602.
36. Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut. 2005; 54:117-121.
37. Nedvídková J, Smitka K, Kopský V, Hainer V. Adiponectin, an adipocyte-derived protein. Physiol Res. 2005; 54:133-140.
38. Turer AT, Browning JD, Ayers CR, et al. Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study. J Clin Endocrinol Metab. 2012; 97:E982-E986.
39. Peter A, Kantartzis K, Machann J, et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes. 2010; 59:3167-3173.
40. Stefan N, Schick F, Häring HU. Sex hormone-binding globulin and risk of type 2 diabetes. N Engl J Med. 2009; 361:2675-2676.
41. Neumeier M, Sigruener A, Eggenhofer E, et al. High molecular weight adiponectin reduces apolipoprotein B and Erelease in human hepatocytes. Biochem Biophys Res Commun. 2007; 12:352:543-548.
42. Liu Q, Yuan B, Lo K.A., Patterson HC, Sun Y, Lodish HF. Adiponec-tin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proc Natl Acad Sci USA. 2012; 109:14568-14573.
43. Ducluzeau PH, Cousin P, Malvoisin E, et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88: 3626-3631.
44. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002; 51:2734-2741.
45. Eglit T, Lember M, Ringmets I, Rajasalu T. Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eur J Endocrinol. 2013; 15:168:385-391.